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Abstract: The risk assessment of mercury (Hg), in both humans and wildlife, is made challenging by great variability in exposure and
health effects. Although disease risk arises following complex interactions between genetic (“nature”) and environmental (“nurture”)
factors, most Hg studies thus far have focused solely on environmental factors. In recent years, ecogenetic-based studies have emerged and
have started to document genetic and epigenetic factors that may indeed inﬂuence the toxicokinetics or toxicodynamics of Hg. The present
study reviews these studies and discusses their utility in terms of Hg risk assessment, management, and policy and offers perspectives on
fruitful areas for future research. In brief, epidemiological studies on populations exposed to inorganic Hg (e.g., dentists and miners) or
methylmercury (e.g., ﬁsh consumers) are showing that polymorphisms in a number of environmentally responsive genes can explain
variations in Hg biomarker values and health outcomes. Studies on mammals (wildlife, humans, rodents) are showing Hg exposures to be
related to epigenetic marks such as DNAmethylation. Such ﬁndings are beginning to increase understanding of the mechanisms of action
of Hg, and in doing so they may help identify candidate biomarkers and pinpoint susceptible groups or life stages. Furthermore, they may
help reﬁne uncertainty factors and thus lead to more accurate risk assessments and improved decision-making. Environ Toxicol Chem
2014;33:1248–1258.# 2013 SETAC
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INTRODUCTION
Ecogenetics evolved from the ﬁeld of pharmacogenetics and
has been deﬁned by Costa and Eaton as the “study of critical
genetic determinants that dictate susceptibility to environmen-
tally inﬂuenced adverse health effects” [1]. Contemporary
ecogenetic thinking emerged in the middle to late 20th century
with seminal contributions by Motulsky [2], Omenn and
Motulsky [3], and Grandjean [4], reasoning that individual
susceptibilities have an ecogenetic basis and that consideration
of ecogenetics can have profound implications for science and
policy. Only in recent years, however, has this ﬁeld grown
substantially. This is due largely to rapid technological
advancements in the laboratory, a deeper understanding of
molecular and functional genetics, and the realization that
epigenetic processes serve as an interface between an organism’s
rapidly changing environment and its relatively ﬁxed genome. In
both ecotoxicology [5] and human health [1,6], it is now widely
accepted that disease risk and progression arise from a complex
interplay between genetic (“nature”) and environmental (“nur-
ture”) factors (Figure 1).
Mercury (Hg) is an environmental contaminant of global
concern whose risk assessment and management can beneﬁt
from an ecogenetic understanding. Reports published by expert
panels and leading scientists have concluded that real-world
exposure to Hgmay be associated with a range of subclinical and
adverse health outcomes in humans and wildlife [7–10]. These
reports acknowledge that tremendous interindividual and
interspecies variation exists in exposure and hazard and that
complex gene–environment interactions may underlie such
variation but as yet remain unresolved. With no resolution to
such variability, decision-making is hampered and uncer-
tain [11,12]. Risk assessments attempt to account for variability
by utilizing default uncertainty factors. Uncertainty factors
increase the margin of safety in an effort to protect sensitive
subgroups, but in doing so they may still prove to be insufﬁcient
or perhaps even overprotective. As we embark on next-
generation risk assessment [12], we must harness emerging
ecogenetic approaches to help increase understanding of true
biological variation across and within individuals and species so
that uncertainty factors are reﬁned and risk assessments
improved.
To identify susceptible subgroups, ecogenetic thinking calls for
attention to both environmental and genetic determinants of
exposure and hazard. In ecotoxicology and human health, however,
most Hg studies are focused solely on resolving environmental or
exposure-related factors (e.g., what are Hg levels in ﬁsh and
consumers?). Although this remains a requisite step in Hg risk
assessment, it has limited use alone in predicting risk. Mercury
science is approaching a point at which ecogenetic methods may
now be used to better identify susceptible groups and perhaps
minimize the reliance on uncertainty factors. In recent years,
increasing numbers of studies have started to document genetic and
epigenetic factors that may inﬂuence the toxicokinetics or
toxicodynamics of Hg. For example, a study on monozygotic
and dizygotic twins revealed Hg biomarker variance stems from
both additive genetic effects and unshared environmental effects,
with the genetic component explaining an estimated 30% of
variance in Hg concentrations [13]. Epidemiological studies on
populations exposed to inorganic Hg (e.g., dentists and miners) or
methylmercury (MeHg; e.g., ﬁsh-consuming populations) are
showing that polymorphisms in a number of environmentally
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responsive genes can explain variations inHg biomarker values and
health outcomes (Tables 1 and 2). Studies on mammalian wildlife
and humans are showing MeHg exposures to be related to
epigenetic markers (Table 3). These ﬁndings, and many others, are
beginning to increase our understanding of the mechanisms of
action of Hg and potentially identify candidate biomarkers of
susceptibility, which may lead to more accurate risk assessments
and improved decision-making. The present study reviews these
studies and discusses their utility in terms of Hg risk assessment,
management, and policy and offers our perspectives on fruitful
areas for future research.
GENETIC FACTORS AND POLYMORPHISMS
Certain genetic pathways (e.g., xenobiotic metabolism, DNA
repair, cell cycle) have evolved to protect the body from
environmental toxicants and stressors. The genes in these
pathways, referred to as “environmentally responsive genes,”
have polymorphic variants that help organisms better cope with
changing environments. In humans, approximately 0.1% of
DNA (3 million base pairs) is variable between individuals, and
some of these polymorphic loci may render individuals more
sensitive or more resistant to environmental contaminants. The
Figure 1. Ecogenetic interactions. In this hypothetical example, at conception, organisms start with a ﬁxed genotype that renders them “healthy” (aa) or
“susceptible” (AA). Over a variable time continuum (x axis, moving from left to right), exposure to environmental stressors can vary and inﬂuence the likelihood of
an organism becoming healthy (green) or sick (red). For example, 2 genetically identical individuals with the same “susceptibility” (AA) genotype can end up with
differing health outcomes based on the environment in which they developed and resided. Likewise, epigenetic changes induced by environmental exposures at
sensitive time points may propagate throughout the life course and inﬂuence health outcomes. Adapted with permission from Kardia [106]. [Color ﬁgure can be
viewed in the online issue which is available at wileyonlinelibrary.com]
Table 1. Signiﬁcant associations between genetic polymorphisms and mercury biomarker levels in epidemiological studies
System Genes
Methylmercury biomarkers Inorganic Hg biomarkers
Alleles associated with
higher biomarker levels
Alleles associated with
lower biomarker levels
Alleles associated with
higher biomarker levels
Alleles associated with
lower biomarker levels
Glutathione
pathway
GCLC, GCLM,
GSS, GSR,
GGT1, GSTA1,
GSTM1, GSTM3,
GSTP1, GSTT1
GCLC rs17883901
T [16,26]; GSTP1
rs1138272 T [16,26];
GSTP1 rs1695 G [16];
GCLM rs41303970
T [28]; GSTM1 and
GSTT1 deletions [16,30];
GSS rs3761144 G [29]
GSTP1 rs1695 G and
rs1138272 T [28,29];
GSTA1 rs3957396 A [16]
GCLM rs41303970
T [27,31] a
GSTT1 deletion [29];
GCLM rs41303970
T [31] a
Metallothionein MT1A, MT1E,
MT1G, MT1M,
MT2A, MT4, MTF1
MT1M rs9936741 C [32];
MT1A rs11640851 C [16];
MT4 rs11643815 A [16]
MT1A
rs8052394 G [32]
MT2A
rs10636 C [32]
MT1M
rs2270836 A [32]
Selenoprotein SEPP1, GPX1, GPX4 None SEPP1
rs7579 T [29]
SEPP1
rs7579 T [29]
None
Xenobiotic
transport
MRP1, MRP2, LAT1, LAT2,
OAT1, OAT3, MDR1, SLC3A2
Not studied Not studied MRP2 rs1885301 A and
rs717620 A; LAT1
rs33916661 G [41]
MRP2 rs2273697 A;
OAT1 rs4149170 G; OAT3
rs4149182 C [41]
aT allele was associated with higher blood Hg among gold miners, merchants, and a reference population with varying inorganic Hg exposures. Blood Hg in this
cohort is likely a better indicator of inorganic Hg because of very high inorganic Hg exposures. T allele was also associated with faster Hg elimination following
burning of Hg-gold amalgam as observed in urine.
rs¼ reference SNP number; GCLC¼ glutamate-cysteine ligase catalytic subunit; GCLM¼ glutamate-cysteine ligase modiﬁer subunit; GSS¼ glutathione
synthetase;GSR¼ glutathione reductase;GGT1¼g-glutamyltransferase 1;GSTA1¼ glutathione S-transferase alpha 1;GSTM1¼ glutathione S-transferasemu 1;
GSTM3¼ glutathione S-transferase mu 3; GSTP1¼ glutathione S-transferase pi 1; GSTT1¼ glutathione S-transferase theta 1; MT1A¼metallothionein 1A;
MT1E¼metallothionein 1E;MT1G¼metallothionein 1G;MT1M¼metallothionein 1M;MT2A¼metallothionein 2A;MT4¼metallothionein 4;MTF1¼metal-
regulatory transcription factor 1; SEPP1¼ selenoprotein P, plasma 1; GPX1¼ glutathione peroxidase 1; GPX4¼ glutathione peroxidase 4; MRP1¼multidrug
resistant protein 1; MRP2¼multidrug resistant protein 2; LAT1¼ large neutral amino acid transporter 1; LAT2¼ large neutral amino acid transporter 2;
OAT1¼ organic anion transporter 1; OAT3¼ organic anion transporter 3; MDR1¼multidrug resistance; SLC3A2¼ solute carrier family 3A2.
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most common type of genetic variability, single nucleotide
polymorphism (SNP), occurs when 1 nucleotide is altered in the
genome sequence, and the variant allele is found in at least 1% of
the population. Although not all SNPs have known phenotypic
effects, many have been shown to confer resistance or
susceptibility to disease [14], impact drug metabolism and
efﬁcacy [15], and inﬂuence toxicokinetics and toxicity of
chemicals or heavy metals. This third phenotypic effect has been
well studied for Pb [16,17], As [18,19], and Be [20,21]. For Hg,
as outlined below, the knowledge of gene–Hg relationships is
now growing.
Gene classes important to Hg toxicokinetics
Genes involved in the toxicokinetics of Hg include those
underlying glutathione (GSH) function (e.g., glutathione
S-transferases [GSTs]), proteins that bind and transport Hg
(e.g., selenoproteins, metallothioneins [MTs]), and xenobiot-
ic transporters (e.g., multidrug resistance proteins [MRPs]).
Polymorphisms in these environmentally responsive genes
are ubiquitous across populations and thus may inﬂuence the
absorption, distribution, metabolism, and elimination of Hg.
Below, we review key ﬁndings relating to the impact of
polymorphisms in these genes and their potential to affect Hg
toxicokinetics.
Glutathione. Glutathione binds inorganic Hg and MeHg,
allowing cellular efﬂux (e.g., via MRPs) and eventually fecal
excretion [22]. Polymorphisms in GSH synthesis pathway genes
(GCLM, GCLC, GSS, GSR) could impact the bioavailability of
GSH for this process. Additionally, GSTs (GSTP1, GSTA1,
GSTM1, GSTM3, GSTT1), a highly polymorphic family of
enzymes, may catalyze the conjugation reaction or may act as
transporters of Hg-GSH conjugates [22]. It has been shown that 2
nonsynonymous GSTP1 SNPs (reference SNP number [rs]1695
and rs1138272) can alter enzyme activity and sensitivity to Hg
inhibition in vitro [23]. The metabolism of Hg can be affected by
variation in the expression or activity of g-glutamyltransferase 1
(GGT1), which cleaves Hg-GSH conjugates prior to cellular
uptake [24]. In mice with a Ggt1 knockout, more MeHg is
excreted and less inorganic Hg is accumulated in the kidneys
following treatment with Hg species [25].
Table 2. Genotype–mercury interactions inﬂuencing health outcomes: Hg biomarkers used, genes with polymorphisms of interest, and health parameters
measured for each study along with any statistically signiﬁcant genotype–Hg biomarker relationships
Type of outcome Health outcome Genes Hg biomarkers
Significant polymorphism–Hg
biomarker interactions on
health outcome Reference
Health
biomarkers
Urinary porphyrin excretion CPOX, UROD Urine CPOX Asn272His (“CPOX4”)
associated with atypical pattern
of porphyrin excretion among
exposed individuals
[42]
MMP-9 and MMP-2 protein levels MMP9, MMP2 Blood, plasma MMP9 microsatellite genotype
impacts MMP-9 activity in
tertile with lowest plasma Hg;
blood Hg modifies relationship
between MMP2 promoter
polymorphism and MMP-2
levels
[49,50]
Nitric oxide production NOS3 Blood Genotype of NOS3 repeat
polymorphism and blood Hg
impact plasma nitrite levels
[51,52]
Subclinical
measures
Low birth weight GSTM1, GSTT1 Blood Increased risk with GSTM1 and
GSTT1 deletions and higher
blood Hg
[48]
Neurobehavioral tests (adults) BDNF, CPOX, SLC6A4
linked region (5-HTTLPR)
Urine Additive effect of BDNF
Val66Met and urine Hg on
tests of visuomotor and finger
tapping speed; additive effect
of CPOX4 and urine Hg on
measures of visuomotor
processing and depression;
additive effect of 5-HTTLPR
deletion and urine Hg on finger
tapping speed and hand
steadiness
[43–45]
Neurobehavioral tests (children) CPOX Urine Interaction between CPOX4
and urine Hg on several
neurobehavioral tests in boys
[47]
Mood, neurological symptoms BDNF, COMT, 5-HTTLPR Urine Additive effect of BDNF
Val66Met with urine Hg on
anxiety and memory
[46,54,55]
Peripheral nerve conduction MTs, GSH pathway,
selenoproteins
Hair, urine None [56]
Clinical
measures
Tremor, neuromotor tests GSH pathway Blood, urine None [31]
Myocardial infarction GSH pathway Erythrocyte None [53]
CPOX¼ coproporphyrinogen oxidase; UROD¼ uroporphyrinogen decarboxylase; MMP9¼matrix metallopeptidase 9; MMP2¼matrix metallopeptidase 2;
NOS3¼ nitric oxide synthase 3; GSTM1¼ glutathione S-transferase mu 1; GSTT1¼ glutathione S-transferase theta 1; SLC6A4¼ solute carrier family 6; 5-
HTTLPR¼ serotonin-transporter-linked polymorphic region; BDNF¼ brain-derived neurotrophic factor; COMT¼ catechol-O-methyltransferase; MT¼metal-
lothionein; GSH¼ glutathione.
1250 Environ Toxicol Chem 33, 2014 N. Basu et al.
Recent epidemiological studies have linked polymorphisms
in GSH pathway genes to hair, blood, and urine Hg levels
(Table 1) [16,26–31]. Note that hair reﬂects exposure to organic
Hg, blood generally reﬂects exposure to organic Hg (though
some inorganic may be present in blood), and urine generally
reﬂects exposure to inorganic Hg (though some of this may have
been derived from organic Hg that was demethylated inside the
body). Collectively, 12 polymorphisms in 10 GSH pathway
genes have been genotyped in various population studies. Most
of the polymorphisms were associated with Hg concentrations in
at least 1 study and at least 1 type of statistical analysis (e.g.,
association with median biomarker levels, effect modiﬁcation on
relationship between estimated exposure and biomarker con-
centration). Despite the use of populations with various
ethnicities and Hg exposure levels, some gene–Hg relationships
were similar across studies. For example, minor alleles of SNPs
in glutamyl-cysteine ligase (rs17883901 in GCLC, rs41303970
in GCLM) were associated with increased MeHg biomarker
levels [16,26,28]. In contrast, the GCLM rs41303970 minor
allele was associated with higher blood, plasma, and urine Hg
levels in Ecuadorian gold miners [27,31]. Not all gene–Hg
relationships were consistent across studies. For example,
Custodio et al. [26] found higher erythrocyte Hg levels in
individuals with the minor allele ofGSTP1 rs1138272 compared
with polyunsaturated fatty acid levels, an indicator of ﬁsh
consumption, whereas Engstr€om et al. [28] observed the
opposite relationship. Similarly to the latter study, lower hair
Hg levels were associated with minor alleles of GSTP1
rs1138272 and rs1695 in a cohort of dental professionals with
ﬁsh consumption patterns similar to those of the US general
population [29].
Metallothionein. Metallothioneins bindmetals, including Hg,
and in doing so inﬂuence heavy metal distribution and protect
against toxicity. Two epidemiological studies have explored the
impact of MT and MT transcription factor (MTF) SNPs on Hg
biomarkers [16,32]. In a cohort of dental professionals, several
signiﬁcant interactions between exposure source and genotype
were observed in models of hair Hg (MT1M rs9936741, MT1A
rs8052394) and urine Hg (MT1M rs2270837, MT2A
rs10636) [32]. Gundacker et al. [16] additionally found 2
SNPs (MT1A rs11640851, MT4 rs11643815) to be associated
with higher hair Hg.
Selenoprotein. Selenoproteins buffer against Hg-induced oxida-
tive stress via Hg binding [33,34]. With up to 10 selenocysteine
residues per protein, selenoprotein P1 (SEPP1) is particularly
equipped for this task [34,35]. The genotype of SEPP1
inﬂuences isoform prevalence and gene expression, and
variation in these parameters may inﬂuence Hg sequestration
or tissue distribution [36–38]. In a cohort of dental professionals,
a regulatory-region SEPP1 SNP (rs7579 in the 3’-untranslated
region [3’UTR]) was differentially associated with hair Hg and
urine Hg levels [29]. A signiﬁcant interaction between ﬁsh
intake and genotype led to lower hair Hg, whereas genotype and
dental amalgam exposure interacted to increase urine Hg among
more highly exposed individuals. Both Hg exposure [33] and
polymorphisms in the encoding genes [39,40] inﬂuence
expression and activity levels of glutathione peroxidases
(GPX), antioxidant proteins typically containing 1 selenocys-
teine residue. Despite a plausible gene–Hg interaction, only 2
GPX polymorphisms have been studied to date, and no
signiﬁcant relationship was observed [29].
Xenobiotic transporter. Xenobiotic transporters, including
the MRP and organic anion transporter (OAT) families, regulate
cellular inﬂux and efﬂux of GSH-Hg or cysteine-Hg conjugates.
In a study of occupationally exposed artisanal gold miners from
4 countries in Africa and Asia, 18 SNPs in 8 transporter genes
were studied; of these, 3 SNPs (MRP2 rs1885301, rs717620;
LAT1 rs33916661) were linked to higher urine Hg levels in at
least 1 population, and 3 were associated with lower urine Hg
(MRP2 rs2273697, OAT1 rs4149170, OAT3 rs4149182) [41].
Evidence of genetic factors impacting Hg toxicodynamics
Beyond the inﬂuence of genetic polymorphisms on Hg
toxicokinetics and biomarker values, growing evidence links
SNPs and other types of genetic polymorphisms to variability in
Hg-associated adverse health outcomes (Table 2).
A large portion of studies to date involving the interaction of
polymorphisms andHg exposure on health outcomes stem from a
single research team that has studied a cohort of male dentists and
female dental assistants with occupational elemental (inorganic)
Hg exposure (Table 2). In these studies, genetic polymorphisms
modiﬁed Hg-health outcome relationships or added to the risk for
the following health effects: 1) atypical urinary porphyrin
excretion—indicative of Hg-induced alterations to the renal
Table 3. Summary of studies exploring epigenetic effects of mercury
Species Tissue/cell type Chemical Effect Reference
Polar bear Brainstem MeHg Reduced global DNA methylation in male bears but not in
female bears
[67]
Mink Occipital cortex MeHg Reduced global DNA methylation, reduced DNMT activity [68]
Chicken Cerebrum MeHg No effect on global DNA methylation or DNMT activity [68]
Yellow perch Telencephalon MeHg No effect on global DNA methylation [68]
Earthworm Whole Hg Reduced global DNA methylation [71]
Mouse Brain hippocampus MeHg Suppression of the Bdnf promoter via hypermethylation,
increased histone H3K27 trimethylation, and decreased histone
H3 acetylation
[73]
Mouse Embryonic stem cells Hg Reversible alterations to heterochromatin Hypermethylation of
Rnd2 gene
[75]
Mouse Embryonic stem cells Hg Reduction of total histone protein levels and H3K27
monomethylation
[74]
Rat Liver MeHg Reduced Dnmt1 and Dnmt3b mRNA expression, decreased
CpG methylation at Cdkn2a promoter, and no effect on global
DNA methylation or SAM abundance
[70]
Rat Primary cultures of embryonic
cortical neural stem cells
MeHg Decreased global DNA methylation, and downregulation of
Dnmt3b mRNA
[69]
Human Blood Hg Hypermethylation of the GSTM1/5 promoter [76]
Human Buccal cells MeHg Hypomethylation of SEPP1 gene among males [77]
MeHg¼methylmercury; DNMT¼DNA methyltransferase; SAM¼S-adenosylmethionine.
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heme biosynthesis pathway—and a nonsynonymous SNP in
CPOX (rs1131857; called CPOX4) [42]; 2) performance on
several neurobehavioral tests including hand steadiness and
ﬁnger tapping with a nonsynonymous SNP in BDNF
(rs6265) [43]; 3) the Symbol Digit Rate test (visuomotor
processing) and Beck’s depression factor with CPOX4 [44]; 4) a
repeat deletion in the promoter of SLC6A4 (called the 5-HTTLPR
short genotype) with ﬁnger tap and hand steadiness tests [45]);
and 5)BDNF rs6265with indicators of anxiety andmemory [46].
Some of the additive effects between Hg exposure and genotype
were gender and occupation speciﬁc. Interactions of CPOX4
were also found among male children (ages 8–18) with similar
urine Hg levels to the dental cohort, though these relationships
were generally not observed among female children [47].
Collectively, these studies highlight the importance of poly-
morphisms directly related to speciﬁc health outcomes in
conferring susceptibility to Hg’s toxic effects. The BDNF gene
(rs6265) appears to be a key polymorphism associated with
several neurobehavioral effects, and other such polymorphisms
may remain unidentiﬁed.
Besides inorganic Hg, interactions have been observed
between blood Hg concentrations, indicative primarily of MeHg
exposure, and polymorphisms inﬂuencing adverse health out-
comes or health biomarkers. The offspring of mothers with
GSTM1 and GSTT1 deletions and higher blood Hg levels had
increased risk for low birth weight [48]. Genotype of a repeat
polymorphism in matrix metalloproteinase, MMP-9, affected
MMP-9 protein levels among ﬁsh-consuming Brazilians with the
lowest plasma Hg levels, and higher MMP-9 levels were
associated with multiple adverse cardiovascular effects [49]. In
the same cohort, an MMP2 promoter polymorphism (rs243865)
affected MMP-2 levels when blood Hg was taken into
accounted [50]. Genotype of a tandem repeat polymorphism
in NOS3 and blood Hg levels are linked to decreased nitric oxide
production, another biomarker of cardiovascular health, among
highly exposed ﬁsh-eaters in Brazil [51]. However, 2 NOS3
SNPs (rs2070744, rs1799983) did not impact plasma nitrite
levels following ﬁsh consumption [52].
Not all studies exploring gene–Hg interactions showed
signiﬁcant links with the assessed health outcomes [31,52–56],
emphasizing the importance of polymorphism selection, Hg
exposure level, and health outcome measure. Most studies with
signiﬁcant associations genotyped variants in pathways related
to the health outcome of interest. Polymorphisms involved in Hg
toxicokinetics may be less likely to impact target organ toxicity,
as noted from the lack of signiﬁcant interactions in several
studies of health outcomes and polymorphisms primarily in the
GSH pathway [31,53,56].
EPIGENETIC FACTORS
Epigenetics is emerging as important to the toxicity of many
classes of environmental contaminants [57,58], including some
metals [59,60]. “Epigenetics” refers to factors affecting gene
expression that are heritable but occur outside of direct changes
to the DNA sequence. Examples of epigenetic endpoints are
histone modiﬁcation, DNA methylation, and RNA interference.
These endpoints are affected by environmental stimuli such as
chemical exposure, stress, parental behavior, and nutritional
deﬁcits. Epigenetic marks left by such stimuli can persist in
tissues as cells divide in the absence of the initial stressor. This
implies that exposures to chemicals at an early life stage can lead
to adverse health outcomes later in life, or even in subsequent
generations. These characteristics have been demonstrated in
several models [57] and have important implications for
environmental toxicology [5].
The epigenetic effects of Hg are a relatively new ﬁeld of
inquiry, especially compared with other contaminants such as
As, Pb, air pollution, and endocrine disruptors [58]. The
epigenome is established during development and is thought
to be sensitive to environmental inﬂuences during this time.
Likewise, MeHg has been proven to be a developmental
neurotoxin in a number of organisms [61], including humans and
wildlife [62]. Another point of epigenetic consideration is that
MeHg is known to have a long latency period between exposure
and adverse health outcomes. For example, at Minamata Bay in
Japan, impaired cognition and dysfunctions in mood and
behavior were found in adults of varying ages who did not
exhibit any clinical effects following developmental, early-life
exposures [63]. Longitudinal birth cohort studies from the Faroe
Islands have documented that developmental exposures (as
determined by cord blood Hg) can be related to later-life adverse
neurological outcomes in children aged 7 and 14 yr [64]. A
latency period of several decades is suggestive of an epigenetic
mode of action, although this has yet to be demonstrated.
Global DNA methylation
DNA methylation is a biochemical process that results in the
addition of a methyl group to a nucleotide [65,66]. A growing
body of research suggests that environmentally relevant MeHg
concentrations can disrupt DNA methylation in mammals
(Table 3). This effect has been observed in both laboratory
animals and ﬁeld studies. Pilsner et al. [67] report an inverse
relationship between brainstem Hg levels and global DNA
methylation in Greenlandic male polar bears (Ursus maritimus).
Similarly, DNA methylation was reduced in the occipital cortex
of juvenile male mink (Neovison vison) raised on a diet of 1 ppm
MeHg for 2 mo, although DNA methylation was unchanged in
animals fed 2 ppm [68]. In these same mink, activity of DNA
methyltransferase (DNMT), the enzyme that establishes and
maintains patterns of DNA methylation in the genome, was also
reduced. In primary cultures of rat cortical embryonic neural
stem cells, subtoxic concentrations of MeHg were associated
with reduced neural stem cell proliferation, decreased global
DNAmethylation, and a slight reduction inDnmt3bmRNA [69].
These effects persisted in daughter cells that were never directly
exposed to MeHg-contaminated media. Several other studies
support a link between MeHg exposure and reduced DNMT
expression. Desaulniers et al. [70] report an MeHg-associated
reduction in Dnmt1 and Dnmt3b mRNA in the livers of female
rats exposed to MeHg during the perinatal period. They did not,
however, observe any effect on global DNA methylation or
levels of the important methyl donor S-adenosylmethionine
(SAM).
It is not clear whether the MeHg-associated depression in
global DNA methylation observed in mammals extends to
other classes of animals. In telencephalons of MeHg-fed
yellow perch (Perca ﬂavescens), there was no change in DNA
methylation [68]. In cerebra of chickens (Gallus gallus
domesticus) exposed in ovo, an MeHg-dependent decrease in
global DNA methylation was observed, but this trend was not
statistically signiﬁcant [68]. In these same chickens, there
were no MeHg-dependent changes in the heart or liver. In
earthworms, global DNA methylation was reduced in relation
to elevated levels of Hg, As, Se, and Sb. This relationship
appeared to be driven mainly by As, a metal with well-
described epigenetic effects [58–60], but Hg was also a
contributing element [71].
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We, as well as others, have suggested that global DNA
methylation could be useful as a biomarker for exposure to Hg
and other chemical agents [5,58]. It is important to note that,
although global DNAmethylation may be a general indicator for
epigenetic stress, we are not aware of any studies that link Hg-
associated global hypomethylation to speciﬁc health outcomes.
In general, abnormal patterns of methylation have been
associated with cancer and neurological, developmental,
immunological, and age-related disorders [72]. More work is
required to identify which areas of the genome are affected by
Hg-associated hypomethylation and what, if any, adverse health
outcomes are associated with reduced methylation status,
particularly in the developing embryo.
Gene-specific effects
In contrast to interpreting studies concerning global changes
in DNA methylation, gene-speciﬁc alterations in epigenetic
status may be more easily interpreted in relation to health
outcomes, In an animal study, Onishchenko et al. [73] linked
MeHg-associated epigenetic repression of brain-derived neuro-
trophic factor (BDNF) to depressive-like symptoms in young
male mice. Exposure to MeHg occurred through maternal
dietary supplementation from gestational day 7 until 7 d after
birth. Along with depressive-like symptoms, MeHg-exposed
male offspring exhibited reduced Bdnf mRNA in the dentate
gyrus. This was attributed to a repressive chromatin state at the
Bdnf promotor. Onishchenko et al. observed DNA hyper-
methylation along with increased histone H3K27 trimethylation
at Bdnf promoter IV and decreased histone H3 acetylation.
These effects persisted in 14-mo-old mice without any further
exposure to MeHg. An in vitro study using mouse embryonic
stem cells found that acute exposure to Hg2þ reduces total
histone protein levels and H3K27 monomethylation [74].
The authors speculate that this may indicate transcriptional
repression. Arai et al. [75] reported that the Rnd2 gene is
hypermethylated in Hg-treated mouse embryonic stem cells. In
contrast, Desaulniers et al. [70] found that the promoter of the
tumor suppressor gene p16INK4awas hypomethylated in MeHg-
exposed female rats.
Two human epidemiology studies have reported MeHg-
associated DNAmethylation of speciﬁc genes. In a pilot study of
58 women, hypermethylation of the GSTM1 promoter in whole
blood was found in those with blood Hg values above 2.9mg/
L [76]. In a study of 131 dental professionals, biomarkers of
MeHg exposure (hair) and elemental Hg exposure (urine) were
related to DNA methylation at global repetitive elements (long
interspersed elements [LINE-1]) and promoter regions of genes
related to epigenetic processes (DNMT1) and Hg interactions
(selenoproteins SEPW1 and SEPP1) [77]. After a series of
multivariable linear regressions, the only statistically signiﬁcant
association was hypomethylation of SEPP1 with hair Hg levels
among males.
Mechanisms
The mechanisms by which Hg affects epigenetic endpoints
have not been resolved. In general, Hg has a strong afﬁnity for
protein thiol and selenol groups, and this is thought to be the root
cause of toxicity [78]. Accordingly, the direct and indirect
targets for Hg are numerous and may include targets involved in
maintaining cellular homeostasis, transducing signals, and
ensuring redox states [79]. Here we focus on possible
mechanisms by which Hg might affect DNA methylation. We
recognize that other epigenetic mechanisms may be affected by
Hg (e.g., histone modiﬁcation or RNA interference), although
DNAmethylation is the most well studied epigenetic endpoint to
date and is the focus below (Figure 2).
DNA methylation is catalyzed by the enzyme DNMT, which
facilitates the transfer of a methyl group from the universal
methyl donor, SAM, to DNA (Figure 2). The covalent addition
of a methyl group to DNA (usually to cytosine residues) is
generally associated with the transcriptional silencing of gene
expression. There is some evidence that MeHg exposure is
associated with reduced expression or biochemical activity of
DNMT [68–70], but it is not known whether Hg can directly
bind to and inhibit the function of DNMT or whether Hg-
associated changes in DNMT function are secondary effects. For
example, reactive products arising from Hg-induced oxidative
stress themselves might affect epigenetic endpoints. DNMT
does not operate in isolation, and thus consideration also should
be given to potential impacts of Hg on complementary enzymes
such as EZH2 (or lysine N-methyltransferase), which helps
recruit DNMTs to particular sites on DNA and also methylates
histones.
Another potential target for Hg is SAM. S-adenosylmethio-
nine is regenerated from S-adenosylhomocysteine (SAH) via the
methionine cycle. Onishchenko et al. [60] suggest that the ratio
of SAM to SAH, sometimes referred to as the methylation
capacity, may be key to understanding how contaminants affect
DNA methylation. A low ratio of SAM to SAH may result in a
deﬁcit of methyl groups for DNA methylation.
Other aspects of the methionine cycle are also important to
both DNA methylation and Hg toxicokinetics. Methionine is an
essential amino acid that serves as a penultimate methyl donor
given that L-methionine is converted into SAM by the enzyme
SAM synthetase. It is interesting to note that MeHg can form
conjugates with L-cysteine and the resulting MeHg-L-cysteine
complex is structurally similar to methionine. In fact, it has been
documented that MeHg-L-cysteine complex can act as a
molecular mimic, substituting for methionine in some cellular
processes [78], including, potentially, the methionine cycle.
Another potential target for Hg is methionine synthase, the
enzyme that converts homocysteine to methionine. It has been
speculated that methionine synthase could be involved with
MeHg-associated changes to DNA methylation status [69];
Figure 2. Mercury-associated effects on DNA methylation and the
methionine cycle. Superscript numbers within shaded boxes refer to studies
that show Hg exposure being associated with that particular compound.
SAM¼S-adenosylmethionine; SAH¼S-adenosylhomocysteine; DNMT¼
DNA methyltransferase; MS¼methionine synthase; 5-MTHF¼ 5-methyl-
tetrahydrofolate; THF¼ tetrahydrofolate. [Color ﬁgure can be viewed in the
online issue which is available at wileyonlinelibrary.com]
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methionine synthase is inhibited by inorganic and ethylated
Hg [80], and the same may be true for MeHg. Inorganic Hg and
MeHg may also bind with homocysteine, and these Hg-
homocysteine conjugates are biologically transportable [81].
An epidemiological analysis of US National Health and
Nutrition Examination Survey (NHANES) data suggest that
blood Hg levels may be inversely associated with plasma
homocysteine levels in younger males [82]. Collectively, these
studies show that Hg may affect the methionine cycle in a
number of ways, and this may subsequently impact the
availability of SAM for DNA methylation.
APPLICATIONS OF ECOGENETICS TO RISK ASSESSMENT
Identifying individuals and organisms susceptible to a
contaminant such as Hg remains at the forefront of ecological
and human health risk assessment. Mercury is considered a
priority pollutant by agencies worldwide (e.g., US Environmen-
tal Protection Agency, US Agency for Toxic Substances and
Disease Registry, Health Canada, World Health Organization
[WHO]), and under the 2013 Minamata Convention it is
proposed to be phased out of many intentional-use products.
Nonetheless, as a persistent chemical, Hg remains globally
dispersed, and levels are projected to increase further in many
areas [83]. Mercury exposures to humans and wildlife will be
commonplace for the foreseeable future with diet (e.g., ﬁsh, rice)
and proximity to point sources or certain products (e.g., small-
scale gold mining, dental amalgams) remaining prominent. For a
number of ethical, legal, and social reasons, it remains judicious
for us to ensure that all individuals and organisms—the average
and the most sensitive—are identiﬁed and protected. In this
section, we discuss how the ecogenetic research reviewed in the
present study may be used to help improve the risk assessment of
Hg and ultimately lead to better decision-making.
Uncertainty factors
Risk assessors in both ecotoxicology and human health apply
uniform uncertainty factors to account for inherent variabili-
ty [84,85]. In the early 2000s, the US National Academy of
Sciences/National Research Council (NAS/NRC) and the Joint
Expert Committee on Food Additives and Contaminants
(JECFA) under the Food and Agriculture Organization and
the WHO calculated a lower limit benchmark dose for MeHg
(see Mergler et al. [9] for discussion). In deriving this dose,
uncertainty factors were applied to account for unquantiﬁable
matters such as interindividual variability and adequacy of
ﬁndings. The NAS/NRC applied an uncertainty factor of 10 to
account for uncertainty divided equally between toxicokinetics
(3.2) and toxicodynamics (3.2). The JECFA report applied
an uncertainty factor of 6.4 to account for variability in
toxicokinetics (3.2) and toxicodynamics (2.0). Though
necessary, such uncertainty factors can have a profound
inﬂuence on managing risk. For example, the NAS/NRC used
a cord blood Hg value of 58mg/L as their benchmark dose lower
limit. After the application of a 10-fold uncertainty factor, the
benchmark value dropped to 5.8mg/L. Although 58mg/L is a
value few would exhibit, 5.7% of women of child-bearing age
(16–49 yr) in the United States have blood Hg levels that exceed
5.8mg/L, with percentages being higher in certain subpopula-
tions (e.g., 16.6% of those self-identiﬁed as Asian, Paciﬁc
Islander, Native American, or multiracial [86]), according to
the NHANES 1999–2002 survey. With a great number of
individuals potentially exposed to MeHg at levels deemed
harmful, ﬁsh consumption advisories have been issued by many
jurisdictions worldwide. Advisories may result in pregnant
women reducing ﬁsh consumption, and although such reduc-
tions would also decrease MeHg exposure, they would also
decrease exposure to key nutrients in ﬁsh [87]. Reduced intake of
such nutrients may result in adverse health outcomes.
Can an ecogenetic approach reﬁne uncertainty factors and
thus better identify sensitive populations? The ultimate goal
would be to describe the genetic components underlying MeHg
variability so that we can reduce uncertainty and utilize
individualistic benchmark values that are protective yet still
allow the beneﬁts of ﬁsh consumption. Here we provide a
simplistic, yet plausible, scenario based on one of our studies.
We calculated estimatedHg intake (microgramsHg per kilogram
body weight per day) based on self-reported ﬁsh consumption
(e.g., portion size, consumption frequency for 28 ﬁsh species)
and average species-speciﬁc Hg levels [29]. As expected,
estimated Hg intake predicted hair Hg levels among 469
individuals. However, inclusion of SEPP1 rs7579 genotype in
the model, a regulatory region SNP, drastically changed
predicted hair Hg concentrations depending on genotypic
subgroup. For nonﬁsh consumers, regardless of genotype, the
model predicted similar hair Hg levels. However, for ﬁsh
consumers, genotype was an important contributor. Hair Hg
predictions for frequent ﬁsh consumers (equivalent of 6 cans of
tuna per week) varied 8-fold depending on genotype: 6.16mg/g
among individuals with the CC genotype compared with
2.14mg/g (CT) and 0.74mg/g (TT).
Exposure biomarkers
A major limitation in the risk assessment of Hg is the
tremendous interindividual variability observed in exposure
biomarkers. For example, in humans, a hair to blood ratio of 250
is used in risk assessment, but this value can vary widely among
populations (mean, 140–370) and individuals (maximum ratio
>600) [88–90]. Calculated half-lives of MeHg range from 33 d
to 120 d in hair, 99 d to 120 d in blood cells, and 47 d to 130 d in
plasma [91]. Variable inorganic Hg retention has also been
observed in humans [92] and mice [93], the latter of which is
strain and gender dependent. Similarly for wildlife, Hg levels in
samples collected noninvasively, such as fur and feathers, can
vary widely compared with internal doses measured in blood or
organs [94,95]. When such data are utilized in validated
exposure assessment models, great discrepancy can exist
between the modeled relationships and the measured biomarker
values. For example, in a reanalysis of ﬁsh consumption surveys
and measured biomarker values from a number of human groups
worldwide, Canuel et al. [96] documented that the normative risk
assessment of MeHg yielded results that were highly variable
(68–573%) in terms of relating modeled hair Hg with measured
hair Hg. A number of factors may help explain this variability
(e.g., recall bias, instrument error), although, as discussed by the
authors, it is also quite likely that unresolved interindividual
genetic differences feature prominently. As outlined in Table 1,
the ﬁrst ecogenetic studies are showing that polymorphisms in
genes within the glutathione, metallothionein, selenoprotein, and
xenobiotic transporter families may affect Hg biomarker values;
and it is hoped that, in the future, consideration of such
information may help to improve the interpretation of exposure
biomarkers, as discussed in the review article by Dorne
et al. [97].
Interspecies differences
The intraspecies differences in Hg toxicokinetics and
toxicodynamics observed in humans also exist for ﬁsh and
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wildlife but have received minimal study. More attention is paid
to differences across species. For example, Heinz et al. [98]
injectedMeHg into eggs of 26 bird species, found variable dose–
response curves and calculated LC50s, and provided some
discourse on sensitivity differences based on taxonomy. For
marine mammals, polar bears are exposed to some of the greatest
Hg levels among all organisms (liver concentrations >100 ppm
dry wt), but surprisingly low levels were found in their brains
(<1 ppm dry wt measured, but>20 ppm expected) [99]. Within
the Mustelidae family, mink and river otters inhabit common
ecosystems but seem to have different abilities to metabolize Hg
in the brain. Compared with otters, mink have a lowered ability
to demethylate organic Hg and accumulate Se in the brain [100].
Similar differences in demethylation and Se accumulation have
also been found in common loons and bald eagles [101]. In these
selected examples, the interspecies differences have been
discussed nearly exclusively in consideration of factors such
as natural history and physiology, although it is likely that
ecogenetics also plays a role. As an example, a previous study
documented that 2 amino acid changes in the avian aryl
hydrocarbon receptor could help predict species sensitivity to
dioxin-like compounds [102]. We wonder whether similar
genetic differences may be uncovered for Hg to help improve
ecological risk assessment.
Nutrient–toxicant interactions
As mentioned previously, ﬁsh are not only a major source of
MeHg but also an important source of essential nutrients, such as
omega-3 fatty acids, that may have positive effects on
physiological systems adversely affected by MeHg. A number
of nutrients or nutritional factors, such as Se, cysteine, protein,
milk, and vitamin E have been shown to affect the toxicokinetics
and toxicodynamics of Hg [103].Much of this evidence has been
gleaned from in vitro or animal studies, although within human
epidemiology there remains continued debate concerning the
protective effects of various nutrients on MeHg-associated
adverse health outcomes [9]. Perhaps some of this debate stems
from the fact that many nutrients, like toxicants, have a strong
ecogenetic basis [104]. For example, an increase in plasma Se
concentrations following a 6-wk supplementation trial varied
signiﬁcantly based on genotype of 2 SEPP1 SNPs (rs7579,
rs3877899), body mass index, and interaction between body
mass index and genotype [36]. Within epigenetics, several
studies have documented that altered exposure of animals and
people to dietary methyl donors (e.g., folate, choline) is related to
predicted alterations in DNA methylation [105]. Although the
task of linking ecogenetic data from Hg and a number of
nutrients into a single study to help tease apart risk–beneﬁts
seems daunting, advances in statistical modeling may prove
useful.
Vulnerable windows and latencies
MeHg is a developmental toxicant, known to exhibit a long
latency of effect. This makes it difﬁcult to relate early-life
exposures and later-life health impacts causally and thus
represents a major challenge to risk assessment. Although
much more research is needed, epigenetics is starting to provide
mechanistic evidence to bridge the temporal gap between
exposure and disease. Mercury-induced changes in DNA
methylation, for example, may result in gene expression changes
that are persistent and traceable. For example, in a study of
neural stem cells that were exposed to MeHg, changes in DNA
methylation were found in cells directly exposed but also in their
daughter cells that were never exposed to MeHg [69]. In other
words, altered DNA methylation may serve as a “memory” of
contaminant exposure [66]. This could potentially help identify
vulnerable windows of susceptibility to toxic effects.
CONCLUSIONS
Mercury is a contaminant of global concern and will remain
so in the foreseeable future. The risk assessment of Hg and
subsequent management decisions have been hampered by great
variability in exposure and health effect, in both humans and
wildlife. With MeHg exposure in humans as an example, debate
continues concerning interindividual variation in adverse
neurodevelopmental outcomes (e.g., differing outcomes in
Faroe vs Seychelles studies), progression of cardiovascular
disease (e.g., hypertension risk), and latencies between exposure
and health effect, which can range from weeks to years as was
observed following the Minamata Bay incident [8–10]. To date,
most studies have tried to account for variability by considering,
for example, pertinent biological or environmental factors such
as age and gender and coexposures to other toxicants and
nutrients; inclusion of such covariates has met with limited
success. There is now growing evidence, as highlighted in the
present study, that an ecogenetic understanding (i.e., genetic
polymorphisms, epigenetic processes) may help uncover
underlying mechanisms of action and better identify susceptible
subpopulations. The ﬁeld is in its infancy, and a number of
potentially exciting avenues of research are emerging as the ﬁeld
moves forward. Below, we provide a few examples for both
genetics and epigenetics.
In genetic studies, ﬁrst, discrepancies among epidemiological
studies seemingly related to differences in exposure character-
istics (e.g., dose, source, Hg species, duration), population
genotype frequencies, Hg biomarkers analyzed, statistical
modeling, and statistical power highlight the need for improved
study designs and communication among research teams.
Standardizing methods across research groups for estimating
Hg exposures (e.g., ﬁsh consumption surveys vs measuring ﬁsh
biomarkers in blood), Hg body burden (collection of all 3 main
biomarkers), and toxicity (e.g., neurobehavioral test batteries)
whenever possible would improve comparability of studies and
increase the weight of evidence for important genetic factors.
Second, the total number of polymorphisms studied to date has
been small, with the majority focused on GSH pathway genes.
Hypothesis-driven, candidate gene research involving environ-
mentally responsive genes should continue, although gene
selection could be organized in a pathway-based manner (i.e.,
multiple genes in a given pathway investigated simultaneously).
In addition, technological advances and reduced costs are now
permitting the analysis of millions of genetic variants via SNP
arrays. Such genome-wide association studies may help uncover
key polymorphisms in genomic regions that have been
unexplored or not previously considered to be important in
Hg risk. Statistical modeling improvements will help move the
ﬁeld toward amore realistic picture of how SNPsmay impact Hg
risk. Third, we are not aware of genetic polymorphism studies in
ﬁsh and wildlife in relation to Hg exposure, and this represents a
potentially fruitful area of research, given that DNA sequencing
costs are not prohibitively expensive.
In epigenetic studies, ﬁrst, the total number of studies
concerned with Hg is limited, so there is a great need to perform
the most basic studies to increase the knowledge base. For
example, research on whether Hg affects DNMT activity,
methionine synthase activity, and SAM levels must be resolved
at the observational, experimental, and mechanistic levels.
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Global DNAmethylation data are of limited use, and future work
should focus on methylation of speciﬁc gene targets. Beyond
DNA methylation, other epigenetic markers (e.g., histone
modiﬁcations) exist that have received very little attention in
terms of Hg exposure. Without such basic knowledge,
interpreting the outcomes of more sophisticated research
outcomes will be challenging. Second, given the promise of
epigenetics as a mechanism to help explain long latencies and
transgenerational effects, carefully designed longitudinal human
studies and multigenerational wildlife studies will need to be
conducted. Third, as with genetics, platforms now exist by which
thousands of DNA methylation marks can be interrogated. Use
of such epigenome-wide association technologies will reveal a
greater picture of regions of the epigenome targeted by Hg and
may provide mechanistic links to toxic outcomes.
Mercury is a contaminant that is being acted on by decision-
makers worldwide, from local settings to the global level. As we
embark on activities that will assess the efﬁcacy of these
decisions, we will need to rely on scientiﬁc advancements and
next-generation risk assessments. It will be necessary to
incorporate emerging ecogenetic approaches to help increase
understanding of the true biological variation across and within
species so that uncertainty factors are reﬁned and risk assess-
ments improved. The tools and basic knowledge for conducting
such studies are now at our disposal. Such activities will need to
be conducted with a constant reminder that disease risk and
progression arise following complex interactions between
genetic (“nature”) and environmental (“nurture”) factors over
time.
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